The melanoma study discussed below provides the strongest evidence for this selective activity
By addressing the various facets of obesity, including hormonal imbalances, metabolic issues, and lifestyle factors, we aim to help our patients not only lose weight but also maintain their progress long-term
Celebrities have historically taken interest in cutting-edge medical interventions, whether its athletes receiving top-of-the-line treatment after an injury or tabloid regulars promoting the latest health supplements
What published clinical research shows: The STEP-1 trial (semaglutide, published in NEJM 2021) demonstrated that participants with obesity or overweight without diabetes who received semaglutide 2.4 mg weekly plus lifestyle intervention experienced mean weight loss of 14.9% over 68 weeks
Endocrinology Advisor Conclusion The 2025 GLP-1 guidelines reflect a paradigm shift in the management of type 2 diabetes, emphasizing the multifaceted benefits of these agents
However, DSIP should be approached carefully because online claims often go far beyond what the research can confidently support